Commonwealth Equity Services, LLC Pacira Bio Sciences, Inc. Transaction History

Commonwealth Equity Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$51.49 - $81.64 $143,811 - $228,020	-2,793 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$60.03 - $76.49 $135,727 - $172,943	-2,261 Reduced 44.74%	2,793 $213,000
Q4 2021 Jan 31, 2022	BUY	$47.97 - $62.21 $242,440 - $314,409	5,054 New	5,054 $304,000
Q2 2021 Aug 11, 2021	SELL	$59.18 - $69.99 $191,092 - $225,997	-3,229 Closed	0 $0
Q1 2021 May 04, 2021	SELL	$59.31 - $78.82 $8,896 - $11,822	-150 Reduced 4.44%	3,229 $226,000
Q4 2020 Feb 11, 2021	BUY	$50.47 - $66.26 $170,538 - $223,892	3,379 New	3,379 $202,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.